The store will not work correctly when cookies are disabled.
N-[4-[Ethyl(isopropyl)amino]phenyl]-3-methyl-5-phenylisoxazole-4-carboxamide
ID: ALA4559136
PubChem CID: 155558077
Max Phase: Preclinical
Molecular Formula: C22H25N3O2
Molecular Weight: 363.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(c1ccc(NC(=O)c2c(C)noc2-c2ccccc2)cc1)C(C)C
Standard InChI: InChI=1S/C22H25N3O2/c1-5-25(15(2)3)19-13-11-18(12-14-19)23-22(26)20-16(4)24-27-21(20)17-9-7-6-8-10-17/h6-15H,5H2,1-4H3,(H,23,26)
Standard InChI Key: ATWJGINVXYPHAD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.7057 -2.9204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6995 -3.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4784 -4.0019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9697 -3.3425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4884 -2.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7868 -3.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2007 -2.6440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1902 -4.0593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0073 -4.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4087 -4.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2251 -4.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6398 -4.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2321 -3.3663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4170 -3.3634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4570 -4.0844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8612 -4.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6784 -4.7996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8699 -3.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6871 -3.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7231 -4.7816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4483 -5.4998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7444 -1.9016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5463 -1.7386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8046 -0.9640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2619 -0.3519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4578 -0.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2033 -1.2937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
4 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
3 20 1 0
16 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
5 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.46 | Molecular Weight (Monoisotopic): 363.1947 | AlogP: 5.14 | #Rotatable Bonds: 6 |
Polar Surface Area: 58.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.90 | CX Basic pKa: 5.42 | CX LogP: 4.37 | CX LogD: 4.36 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.66 | Np Likeness Score: -1.69 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |